NCT00004667已完成1 期
Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease
National Center for Research Resources (NCRR)0 个研究点目标入组 10 人开始时间: 1993年10月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
OBJECTIVES: I. Evaluate the effect of a new von Willebrand factor concentrate on bleeding time, in vivo recovery, and circulating half-life of the infused factor in patients with von Willebrand's disease.
II. Assess the safety of von Willebrand factor in these patients.
详细描述
PROTOCOL OUTLINE: Patients receive 1 dose of von Willebrand factor concentrate. Timed blood studies are performed for the next 96 hours.
Patients are followed every 2 weeks for 16 weeks, and at 24, 36, and 52 weeks.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 0 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •PROTOCOL ENTRY CRITERIA:
- •von Willebrand's disease
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac ProcedureHeart FailureAortic StenosisNCT02628509University Hospital, Lille500
已完成
不适用
Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)Von Willebrands DiseaseNCT02466789Jonathan Roberts134
已完成
3 期
Study of Biostate® in Children With Hemophilia AHemophilia ANCT01229007CSL Behring35
已完成
3 期
Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing SurgeryVon Willebrand DiseaseNCT02283268Baxalta now part of Shire24
Unknown
不适用
Evaluation of Von Willebrand Factor as a Marker For Early Diagnosis of Acute Respiratory Distress Syndrome (A.R.D.S) in Comparison to Interleukin 6 [IL-6]ARDS, HumanNCT04317469Ain Shams University60